Dec 4, 2017
The following is an excerpt from a press release by aTyr Pharma, Inc detailing their new study focusing on a potential therapy for treating interstitial lung diseases: SAN DIEGO, Nov. 27, 2017 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics...Topics: Research
Nov 23, 2017
Last year we asked FSR Ambassador, Mark Landiak to share what he was grateful for during the holiday season. A year later it all still rings true. When FSR asked me if I’d write a blog on what I’m grateful for, I almost didn’t know where to start. I’m often up...Topics: Patient Voices
Nov 20, 2017
FSR Executive Director Ginger Spitzer attended the 2017 ATS Public Advisory Roundtable Planning Meeting on Nov 17-18 in Miami. Our membership in PAR allows FSR to continue our work toward advocating for patients and ensuring the patient perspective into clinical and...Topics: Community Partners/ News
Nov 7, 2017
Sarcoidosis patient and FSR Board of Directors member Karen Duffy has published her second book full of wit and wisdom on living with chronic illness. “Backbone: Living with Chronic Pain without Turning into One” is currently the #1 Best Seller in the...Topics: News/ Patient Voices
